Stocks Health care DWTX
NASDAQ · Health careDogwood Therapeutics, Inc. (DWTX)
It posted a net loss of $36M. At June 30, 2026 it held $9.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What Dogwood Therapeutics, Inc. does
Dogwood Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DWTX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$34.3M | -$7.13 | n/a |
| 2024 | n/a | -$12.3M | -$12.52 | n/a |
| 2023 | n/a | -$5.3M | -$7.05 | n/a |
| 2022 | n/a | -$12.2M | -$27.95 | n/a |
| 2021 | n/a | -$16M | -$48.34 | n/a |
| 2021 | n/a | -$10.3M | -$52.88 | n/a |
Latest SEC filings
What Dogwood Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- June 17, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026
- May 14, 2026
- April 27, 2026
- April 27, 2026Proxy statement DEF 14A
- April 17, 2026Preliminary proxy statement PRE 14A
Questions about DWTX
What does Dogwood Therapeutics, Inc. do?
Dogwood Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DWTX.
Is Dogwood Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $36M.
When did Dogwood Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Follow DWTX
Get an email when Dogwood Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow DWTX: get an email when it filesWhere the numbers come from
Financial figures are the values Dogwood Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.